RecruitingNCT07076238
Biomarkers of Phage Treatment Response in NTM and Other Infections
Studying OBSOLETE: Mycobacterium xenopi infection
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Doreen Addrizzo-Harris, MD, FCCPNYU Langone Health
- Intervention
- Bacteriophage Treatment(biological)
- Enrollment
- 100 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2032
Study locations (1)
- NYU Langone Health, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07076238 on ClinicalTrials.govOther trials for OBSOLETE: Mycobacterium xenopi infection
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: Mycobacterium xenopi infection →